Pluristem Therapeutics Inc (PSTI)

[FDApproved]

Pluristem Is An R&D Machine.

Pre-Clinical Studies: From Website


PLX cells have demonstrated efficacy in preclinical studies in models of ischemic stroke, neuropathic and inflammatory pain, graft versus host disease (GvHD), pre-eclampsia, tendinosis, myocardial infarction, pulmonary fibrosis, multiple sclerosis, and pulmonary hypertension. Our research department continues to study the mechanisms of action of our different cell products, conducts preclinical studies of our two lead products in additional indications, and continues to develop new products using our proprietary 3D cell expansion platform technology.